TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE AFTER LISOCABTAGENE MARALEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA von Siddiqi, T., Dorritie, K.A., Soumerai, J.D., Stephens, D.M., Dubovsky, J.A., Gillenwater, H.H., Gong, L., Thorpe, J., Yang, L., Wierda, W.G.

Volltext

TIME FROM DIAGNOSIS TO 2ND TREATMENT IS A PROMISING SURROGATE FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA von Soumerai, J.D., Ni, A., Batlevi, C., Alperovich, A., Bantilan, K.S., Palomba, M., Gerecitano, J.F., Noy, A., Hamlin, P., Moskowitz, C.H., Copeland, A.R., Matasar, M.J., Drullinsky, P.R., Hamilton, A., Horwitz, S.M., Intlekofer, A.M., Kumar, A., Moskowitz, A., Portlock, C., Sauter, C., Straus, D.J., Caron, P., Ying, Z., Smith, K., Younes, A., Zelenetz, A.D.

Volltext